| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Defects, Congenital | 39 | 2023 | 365 | 5.290 |
Why?
|
| Cardiac Surgical Procedures | 40 | 2022 | 479 | 4.740 |
Why?
|
| Loeys-Dietz Syndrome | 13 | 2023 | 21 | 3.760 |
Why?
|
| Aortic Valve | 18 | 2024 | 244 | 3.570 |
Why?
|
| Heart Transplantation | 17 | 2021 | 717 | 2.930 |
Why?
|
| Pulmonary Valve | 8 | 2024 | 34 | 2.630 |
Why?
|
| Blood Vessel Prosthesis Implantation | 16 | 2019 | 227 | 2.590 |
Why?
|
| Ductus Arteriosus, Patent | 6 | 2022 | 40 | 2.060 |
Why?
|
| Infant | 58 | 2022 | 3173 | 2.050 |
Why?
|
| Cardiopulmonary Bypass | 15 | 2020 | 158 | 1.960 |
Why?
|
| Hypoplastic Left Heart Syndrome | 7 | 2024 | 77 | 1.960 |
Why?
|
| Aortic Valve Insufficiency | 9 | 2024 | 132 | 1.910 |
Why?
|
| Heart Valve Prosthesis Implantation | 11 | 2021 | 178 | 1.870 |
Why?
|
| Aortic Aneurysm, Thoracic | 10 | 2021 | 89 | 1.860 |
Why?
|
| Marfan Syndrome | 13 | 2023 | 28 | 1.790 |
Why?
|
| Child | 61 | 2024 | 7210 | 1.760 |
Why?
|
| Child, Preschool | 46 | 2021 | 3753 | 1.560 |
Why?
|
| Aortic Aneurysm | 9 | 2019 | 80 | 1.500 |
Why?
|
| Aorta | 9 | 2022 | 289 | 1.490 |
Why?
|
| Aorta, Thoracic | 10 | 2023 | 168 | 1.390 |
Why?
|
| Infant, Newborn | 37 | 2024 | 2487 | 1.390 |
Why?
|
| Reoperation | 20 | 2024 | 603 | 1.340 |
Why?
|
| Extracorporeal Membrane Oxygenation | 6 | 2024 | 184 | 1.310 |
Why?
|
| Replantation | 6 | 2018 | 36 | 1.240 |
Why?
|
| Norwood Procedures | 4 | 2024 | 40 | 1.240 |
Why?
|
| Heart Valve Diseases | 3 | 2024 | 115 | 1.230 |
Why?
|
| Vascular Surgical Procedures | 8 | 2021 | 149 | 1.160 |
Why?
|
| Heart Septal Defects, Atrial | 3 | 2024 | 67 | 1.130 |
Why?
|
| Humans | 148 | 2024 | 89500 | 1.120 |
Why?
|
| Retrospective Studies | 45 | 2024 | 9097 | 1.070 |
Why?
|
| Postoperative Complications | 23 | 2020 | 2290 | 1.050 |
Why?
|
| Tetralogy of Fallot | 6 | 2022 | 44 | 1.040 |
Why?
|
| Aortic Valve Stenosis | 3 | 2024 | 144 | 1.030 |
Why?
|
| Treatment Outcome | 34 | 2024 | 8200 | 1.010 |
Why?
|
| Vascular Grafting | 2 | 2017 | 16 | 0.990 |
Why?
|
| Male | 84 | 2024 | 42439 | 0.980 |
Why?
|
| Pulmonary Artery | 10 | 2022 | 320 | 0.970 |
Why?
|
| Saphenous Vein | 3 | 2012 | 61 | 0.970 |
Why?
|
| Female | 92 | 2023 | 46329 | 0.950 |
Why?
|
| Heart Failure | 6 | 2018 | 1191 | 0.930 |
Why?
|
| Risk Assessment | 10 | 2019 | 2303 | 0.900 |
Why?
|
| Aortic Diseases | 4 | 2023 | 102 | 0.880 |
Why?
|
| Adolescent | 41 | 2021 | 9290 | 0.870 |
Why?
|
| Heart-Assist Devices | 6 | 2019 | 763 | 0.870 |
Why?
|
| Heart Valve Prosthesis | 5 | 2017 | 98 | 0.850 |
Why?
|
| Follow-Up Studies | 19 | 2021 | 3658 | 0.840 |
Why?
|
| Time Factors | 18 | 2021 | 5330 | 0.820 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 2 | 2018 | 14 | 0.780 |
Why?
|
| Forecasting | 3 | 2018 | 304 | 0.780 |
Why?
|
| Stents | 1 | 2024 | 409 | 0.750 |
Why?
|
| Balloon Valvuloplasty | 1 | 2021 | 8 | 0.750 |
Why?
|
| Diverticulum | 2 | 2023 | 45 | 0.730 |
Why?
|
| Transposition of Great Vessels | 3 | 2018 | 24 | 0.720 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2020 | 58 | 0.690 |
Why?
|
| Infant, Premature, Diseases | 2 | 2018 | 77 | 0.690 |
Why?
|
| Survival Rate | 13 | 2021 | 1886 | 0.680 |
Why?
|
| Heart Septal Defects, Ventricular | 2 | 2018 | 69 | 0.650 |
Why?
|
| Nitric Oxide | 1 | 2020 | 279 | 0.640 |
Why?
|
| Patient Readmission | 5 | 2020 | 353 | 0.640 |
Why?
|
| Bioprosthesis | 3 | 2017 | 39 | 0.630 |
Why?
|
| Mitral Valve Insufficiency | 2 | 2020 | 192 | 0.630 |
Why?
|
| Infant, Extremely Low Birth Weight | 1 | 2018 | 26 | 0.620 |
Why?
|
| Patient Selection | 3 | 2018 | 676 | 0.600 |
Why?
|
| Tricuspid Valve Insufficiency | 2 | 2018 | 115 | 0.590 |
Why?
|
| Blood Vessel Prosthesis | 7 | 2018 | 244 | 0.590 |
Why?
|
| Prosthesis Implantation | 1 | 2018 | 126 | 0.580 |
Why?
|
| Ventricular Outflow Obstruction | 3 | 2017 | 22 | 0.570 |
Why?
|
| Mitral Valve | 3 | 2020 | 262 | 0.570 |
Why?
|
| Blalock-Taussig Procedure | 2 | 2017 | 12 | 0.570 |
Why?
|
| Heart Diseases | 4 | 2013 | 298 | 0.570 |
Why?
|
| Databases, Factual | 10 | 2023 | 859 | 0.570 |
Why?
|
| Coronary Vessels | 4 | 2022 | 192 | 0.560 |
Why?
|
| Sinus of Valsalva | 5 | 2012 | 18 | 0.550 |
Why?
|
| Mitral Valve Annuloplasty | 1 | 2016 | 16 | 0.550 |
Why?
|
| Aneurysm, False | 4 | 2018 | 54 | 0.540 |
Why?
|
| Risk Factors | 17 | 2021 | 5518 | 0.530 |
Why?
|
| Connective Tissue Diseases | 1 | 2016 | 70 | 0.520 |
Why?
|
| Hypertension, Pulmonary | 3 | 2020 | 354 | 0.510 |
Why?
|
| ABO Blood-Group System | 3 | 2021 | 58 | 0.510 |
Why?
|
| Prosthesis Design | 6 | 2018 | 298 | 0.510 |
Why?
|
| Heart Ventricles | 6 | 2017 | 779 | 0.500 |
Why?
|
| Vascular Resistance | 2 | 2014 | 103 | 0.490 |
Why?
|
| Hospital Mortality | 7 | 2019 | 391 | 0.490 |
Why?
|
| Sternotomy | 4 | 2016 | 24 | 0.490 |
Why?
|
| End Stage Liver Disease | 1 | 2015 | 61 | 0.480 |
Why?
|
| Coronary Aneurysm | 2 | 2018 | 16 | 0.470 |
Why?
|
| Cyanosis | 2 | 2013 | 10 | 0.470 |
Why?
|
| Subclavian Artery | 4 | 2023 | 43 | 0.470 |
Why?
|
| Kaplan-Meier Estimate | 11 | 2020 | 849 | 0.470 |
Why?
|
| Cryopreservation | 2 | 2012 | 70 | 0.460 |
Why?
|
| Glial Fibrillary Acidic Protein | 4 | 2020 | 59 | 0.460 |
Why?
|
| Imaging, Three-Dimensional | 5 | 2018 | 599 | 0.450 |
Why?
|
| Aortic Coarctation | 2 | 2019 | 36 | 0.440 |
Why?
|
| Heart Septal Defects | 2 | 2012 | 32 | 0.440 |
Why?
|
| Echocardiography | 8 | 2024 | 939 | 0.440 |
Why?
|
| Arteriovenous Shunt, Surgical | 2 | 2013 | 72 | 0.430 |
Why?
|
| Pulmonary Veins | 1 | 2014 | 93 | 0.430 |
Why?
|
| Cardiac Catheterization | 4 | 2020 | 303 | 0.430 |
Why?
|
| Pulmonary Valve Stenosis | 2 | 2022 | 18 | 0.430 |
Why?
|
| Natriuretic Peptide, Brain | 4 | 2020 | 51 | 0.430 |
Why?
|
| Autografts | 2 | 2024 | 29 | 0.420 |
Why?
|
| Coronary Vessel Anomalies | 4 | 2022 | 41 | 0.400 |
Why?
|
| Models, Statistical | 1 | 2015 | 574 | 0.390 |
Why?
|
| Tissue Engineering | 3 | 2019 | 189 | 0.390 |
Why?
|
| Interleukin-1 Receptor-Like 1 Protein | 3 | 2020 | 12 | 0.390 |
Why?
|
| Prospective Studies | 11 | 2020 | 4305 | 0.360 |
Why?
|
| Logistic Models | 8 | 2019 | 1214 | 0.350 |
Why?
|
| Double Outlet Right Ventricle | 2 | 2022 | 6 | 0.350 |
Why?
|
| Peptide Fragments | 3 | 2020 | 462 | 0.330 |
Why?
|
| Echocardiography, Doppler | 3 | 2019 | 186 | 0.330 |
Why?
|
| Myocytes, Cardiac | 3 | 2017 | 314 | 0.330 |
Why?
|
| Cardiomyopathy, Dilated | 3 | 2009 | 101 | 0.330 |
Why?
|
| Heart Arrest | 2 | 2024 | 277 | 0.330 |
Why?
|
| Blood Group Incompatibility | 1 | 2008 | 20 | 0.320 |
Why?
|
| Printing, Three-Dimensional | 3 | 2018 | 44 | 0.320 |
Why?
|
| Adult | 33 | 2022 | 26660 | 0.320 |
Why?
|
| Length of Stay | 5 | 2020 | 742 | 0.320 |
Why?
|
| Truncus Arteriosus | 1 | 2008 | 3 | 0.310 |
Why?
|
| Extracorporeal Circulation | 2 | 2007 | 34 | 0.310 |
Why?
|
| Young Adult | 12 | 2024 | 6355 | 0.310 |
Why?
|
| Survival Analysis | 4 | 2018 | 1496 | 0.310 |
Why?
|
| Transplantation, Autologous | 3 | 2024 | 345 | 0.300 |
Why?
|
| Computer-Aided Design | 2 | 2018 | 17 | 0.300 |
Why?
|
| Biomarkers | 9 | 2020 | 1767 | 0.300 |
Why?
|
| Models, Anatomic | 2 | 2018 | 92 | 0.300 |
Why?
|
| Recovery of Function | 2 | 2020 | 293 | 0.290 |
Why?
|
| Bioprinting | 2 | 2017 | 13 | 0.290 |
Why?
|
| Dilatation | 2 | 2024 | 48 | 0.280 |
Why?
|
| Coronary Artery Bypass | 1 | 2009 | 236 | 0.280 |
Why?
|
| Heart-Lung Transplantation | 2 | 2006 | 19 | 0.270 |
Why?
|
| Lung Transplantation | 2 | 2019 | 293 | 0.270 |
Why?
|
| Polytetrafluoroethylene | 2 | 2003 | 74 | 0.270 |
Why?
|
| Heart Arrest, Induced | 3 | 2003 | 29 | 0.270 |
Why?
|
| Cerebrovascular Circulation | 4 | 2010 | 229 | 0.260 |
Why?
|
| Perfusion | 2 | 2016 | 237 | 0.250 |
Why?
|
| Cystic Fibrosis | 2 | 2006 | 115 | 0.250 |
Why?
|
| Postoperative Period | 4 | 2019 | 301 | 0.250 |
Why?
|
| Respiratory Insufficiency | 3 | 2020 | 161 | 0.250 |
Why?
|
| Proportional Hazards Models | 5 | 2020 | 846 | 0.250 |
Why?
|
| Echocardiography, Transesophageal | 3 | 2021 | 348 | 0.250 |
Why?
|
| Galectin 3 | 3 | 2019 | 20 | 0.250 |
Why?
|
| Registries | 6 | 2021 | 790 | 0.240 |
Why?
|
| Surgical Flaps | 1 | 2007 | 250 | 0.240 |
Why?
|
| Ultrasonography, Prenatal | 3 | 2020 | 152 | 0.230 |
Why?
|
| Pneumothorax | 3 | 2001 | 53 | 0.230 |
Why?
|
| Courage | 1 | 2023 | 7 | 0.220 |
Why?
|
| Resuscitation | 1 | 2024 | 110 | 0.220 |
Why?
|
| Funnel Chest | 2 | 2013 | 8 | 0.220 |
Why?
|
| Sternum | 2 | 2013 | 35 | 0.220 |
Why?
|
| Candidiasis | 1 | 2003 | 37 | 0.220 |
Why?
|
| Pulmonary Valve Insufficiency | 1 | 2003 | 12 | 0.220 |
Why?
|
| Dilatation, Pathologic | 3 | 2018 | 55 | 0.220 |
Why?
|
| Severity of Illness Index | 4 | 2018 | 1849 | 0.220 |
Why?
|
| Prognosis | 8 | 2020 | 3777 | 0.220 |
Why?
|
| Internal Mammary-Coronary Artery Anastomosis | 1 | 2003 | 9 | 0.220 |
Why?
|
| Age Factors | 5 | 2018 | 1876 | 0.220 |
Why?
|
| Drainage | 2 | 2019 | 165 | 0.210 |
Why?
|
| Foramen Ovale, Patent | 2 | 2017 | 18 | 0.210 |
Why?
|
| Tricuspid Atresia | 1 | 2022 | 4 | 0.210 |
Why?
|
| Hemodynamics | 5 | 2017 | 731 | 0.210 |
Why?
|
| Truncus Arteriosus, Persistent | 1 | 2022 | 6 | 0.210 |
Why?
|
| Medicine | 1 | 2023 | 91 | 0.210 |
Why?
|
| Hypothermia, Induced | 4 | 2013 | 82 | 0.210 |
Why?
|
| Prevalence | 4 | 2023 | 1245 | 0.210 |
Why?
|
| Fontan Procedure | 2 | 2017 | 56 | 0.200 |
Why?
|
| Acute Kidney Injury | 2 | 2020 | 316 | 0.200 |
Why?
|
| Abnormalities, Multiple | 2 | 2019 | 234 | 0.200 |
Why?
|
| Shock, Cardiogenic | 1 | 2003 | 107 | 0.200 |
Why?
|
| Fatal Outcome | 5 | 2016 | 296 | 0.200 |
Why?
|
| Chest Tubes | 2 | 2001 | 24 | 0.200 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2019 | 331 | 0.200 |
Why?
|
| Vascular Diseases | 1 | 2023 | 118 | 0.200 |
Why?
|
| Societies, Medical | 4 | 2017 | 578 | 0.190 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2001 | 81 | 0.180 |
Why?
|
| Coronary Occlusion | 1 | 2020 | 7 | 0.180 |
Why?
|
| Endothelium-Dependent Relaxing Factors | 1 | 2020 | 1 | 0.180 |
Why?
|
| Respiratory Paralysis | 1 | 2020 | 8 | 0.180 |
Why?
|
| Ligation | 2 | 2018 | 51 | 0.180 |
Why?
|
| Phrenic Nerve | 1 | 2020 | 42 | 0.180 |
Why?
|
| Spheroids, Cellular | 2 | 2017 | 31 | 0.180 |
Why?
|
| Intraoperative Period | 1 | 2020 | 91 | 0.180 |
Why?
|
| Diaphragm | 1 | 2020 | 50 | 0.180 |
Why?
|
| Formative Feedback | 1 | 2020 | 13 | 0.180 |
Why?
|
| Burns, Inhalation | 1 | 2020 | 4 | 0.180 |
Why?
|
| Gynecological Examination | 1 | 2020 | 19 | 0.170 |
Why?
|
| Administration, Inhalation | 1 | 2020 | 192 | 0.170 |
Why?
|
| Situs Inversus | 2 | 2004 | 15 | 0.170 |
Why?
|
| Scimitar Syndrome | 1 | 2019 | 3 | 0.170 |
Why?
|
| Vascular Malformations | 1 | 2019 | 19 | 0.170 |
Why?
|
| Heart Aneurysm | 1 | 2019 | 22 | 0.170 |
Why?
|
| Illinois | 1 | 2021 | 484 | 0.170 |
Why?
|
| Surgery, Computer-Assisted | 2 | 2017 | 98 | 0.170 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2000 | 74 | 0.160 |
Why?
|
| Waiting Lists | 2 | 2018 | 185 | 0.160 |
Why?
|
| Creatinine | 1 | 2020 | 294 | 0.160 |
Why?
|
| Cholecystectomy, Laparoscopic | 1 | 1999 | 57 | 0.160 |
Why?
|
| Intestinal Obstruction | 1 | 1999 | 89 | 0.160 |
Why?
|
| Albinism, Oculocutaneous | 1 | 2018 | 2 | 0.160 |
Why?
|
| Tomography, X-Ray Computed | 6 | 2018 | 2666 | 0.160 |
Why?
|
| Maternal Inheritance | 1 | 2018 | 4 | 0.160 |
Why?
|
| Infant Mortality | 1 | 2018 | 59 | 0.160 |
Why?
|
| Mosaicism | 1 | 2018 | 70 | 0.160 |
Why?
|
| North America | 1 | 2018 | 184 | 0.150 |
Why?
|
| Infant, Premature | 2 | 2018 | 298 | 0.150 |
Why?
|
| Obstetrics | 1 | 2020 | 123 | 0.150 |
Why?
|
| Goals | 1 | 2018 | 67 | 0.150 |
Why?
|
| Aortic Stenosis, Supravalvular | 1 | 2017 | 4 | 0.150 |
Why?
|
| Patient-Specific Modeling | 1 | 2017 | 20 | 0.150 |
Why?
|
| Fetoscopy | 1 | 2017 | 9 | 0.150 |
Why?
|
| Virtual Reality | 1 | 2018 | 24 | 0.150 |
Why?
|
| Brain Injuries | 1 | 2020 | 165 | 0.150 |
Why?
|
| Arterial Switch Operation | 1 | 2017 | 5 | 0.150 |
Why?
|
| Ultrasonography | 5 | 2009 | 711 | 0.150 |
Why?
|
| Genotyping Techniques | 1 | 2018 | 68 | 0.150 |
Why?
|
| Rewarming | 2 | 2016 | 5 | 0.150 |
Why?
|
| Statistics, Nonparametric | 1 | 2018 | 305 | 0.150 |
Why?
|
| Hypotension | 3 | 2014 | 71 | 0.140 |
Why?
|
| Propensity Score | 1 | 2018 | 148 | 0.140 |
Why?
|
| Fetal Diseases | 1 | 2017 | 82 | 0.140 |
Why?
|
| Predictive Value of Tests | 4 | 2020 | 1727 | 0.140 |
Why?
|
| Oxygenators, Membrane | 1 | 2016 | 2 | 0.140 |
Why?
|
| Blood Transfusion | 1 | 2018 | 170 | 0.140 |
Why?
|
| Homeostasis | 2 | 2010 | 417 | 0.140 |
Why?
|
| Multivariate Analysis | 3 | 2014 | 984 | 0.140 |
Why?
|
| Wound Closure Techniques | 1 | 2016 | 15 | 0.140 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2017 | 61 | 0.140 |
Why?
|
| Lung Diseases | 1 | 2019 | 272 | 0.140 |
Why?
|
| Simulation Training | 1 | 2018 | 98 | 0.140 |
Why?
|
| Magnetic Resonance Angiography | 4 | 2018 | 275 | 0.140 |
Why?
|
| Intestines | 1 | 1999 | 416 | 0.140 |
Why?
|
| Brachiocephalic Trunk | 2 | 2007 | 14 | 0.140 |
Why?
|
| Cardiology | 1 | 2017 | 115 | 0.130 |
Why?
|
| Trachea | 1 | 2017 | 291 | 0.130 |
Why?
|
| Tissue Scaffolds | 1 | 2017 | 115 | 0.130 |
Why?
|
| Health Status | 1 | 2018 | 371 | 0.130 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2020 | 1928 | 0.130 |
Why?
|
| Double-Blind Method | 1 | 2020 | 1708 | 0.130 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2016 | 60 | 0.130 |
Why?
|
| Thrombosis | 1 | 2019 | 301 | 0.130 |
Why?
|
| Biocompatible Materials | 1 | 2017 | 198 | 0.130 |
Why?
|
| Cohort Studies | 3 | 2019 | 2876 | 0.130 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2016 | 55 | 0.130 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2017 | 118 | 0.130 |
Why?
|
| Middle Aged | 17 | 2019 | 25973 | 0.130 |
Why?
|
| Mutation | 5 | 2014 | 4158 | 0.120 |
Why?
|
| Transforming Growth Factor beta | 2 | 2008 | 326 | 0.120 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2014 | 39 | 0.120 |
Why?
|
| United States | 5 | 2019 | 7035 | 0.120 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2014 | 91 | 0.120 |
Why?
|
| Tissue Donors | 2 | 2008 | 496 | 0.120 |
Why?
|
| Organ Sparing Treatments | 2 | 2024 | 46 | 0.110 |
Why?
|
| Lung | 2 | 2019 | 1270 | 0.110 |
Why?
|
| Measles virus | 1 | 2012 | 14 | 0.110 |
Why?
|
| Endocarditis | 2 | 2016 | 22 | 0.110 |
Why?
|
| Measles | 1 | 2012 | 16 | 0.100 |
Why?
|
| Thymocytes | 1 | 2012 | 31 | 0.100 |
Why?
|
| Odds Ratio | 1 | 2014 | 682 | 0.100 |
Why?
|
| Monitoring, Intraoperative | 2 | 2010 | 109 | 0.100 |
Why?
|
| History, 20th Century | 1 | 2013 | 312 | 0.100 |
Why?
|
| Peritoneal Dialysis | 1 | 1992 | 31 | 0.100 |
Why?
|
| Prosthesis Fitting | 1 | 2011 | 16 | 0.100 |
Why?
|
| Polyethylene Terephthalates | 1 | 2011 | 18 | 0.100 |
Why?
|
| Thymus Gland | 1 | 2012 | 197 | 0.100 |
Why?
|
| Health Status Indicators | 1 | 2012 | 103 | 0.100 |
Why?
|
| Vena Cava, Superior | 2 | 2009 | 60 | 0.100 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2011 | 45 | 0.100 |
Why?
|
| Cell Differentiation | 2 | 2017 | 1529 | 0.100 |
Why?
|
| Pregnancy | 4 | 2020 | 3035 | 0.090 |
Why?
|
| Death, Sudden, Cardiac | 2 | 2008 | 52 | 0.090 |
Why?
|
| Baltimore | 1 | 2010 | 40 | 0.090 |
Why?
|
| Anastomosis, Surgical | 2 | 2009 | 274 | 0.090 |
Why?
|
| Internship and Residency | 1 | 2020 | 1055 | 0.090 |
Why?
|
| Myocardium | 3 | 2018 | 572 | 0.090 |
Why?
|
| Oximetry | 2 | 2010 | 81 | 0.090 |
Why?
|
| Respiratory Tract Infections | 1 | 2011 | 106 | 0.090 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2010 | 36 | 0.090 |
Why?
|
| Disease Outbreaks | 1 | 2011 | 156 | 0.090 |
Why?
|
| Heart Atria | 2 | 2020 | 282 | 0.090 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2016 | 3462 | 0.090 |
Why?
|
| Hydrocortisone | 1 | 2011 | 301 | 0.090 |
Why?
|
| Seasons | 1 | 2011 | 238 | 0.080 |
Why?
|
| Combined Modality Therapy | 1 | 2013 | 1705 | 0.080 |
Why?
|
| Maryland | 2 | 2019 | 43 | 0.080 |
Why?
|
| Protein Precursors | 2 | 2020 | 140 | 0.080 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2012 | 447 | 0.080 |
Why?
|
| AIDS-Related Opportunistic Infections | 2 | 2001 | 33 | 0.080 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2010 | 80 | 0.080 |
Why?
|
| Cardiac Tamponade | 1 | 2009 | 21 | 0.080 |
Why?
|
| Palliative Care | 3 | 2007 | 264 | 0.080 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2012 | 597 | 0.080 |
Why?
|
| Proteins | 1 | 2014 | 786 | 0.080 |
Why?
|
| Histocompatibility Testing | 1 | 2008 | 137 | 0.080 |
Why?
|
| Heart Bypass, Right | 1 | 2008 | 12 | 0.080 |
Why?
|
| Incidence | 3 | 2020 | 1598 | 0.080 |
Why?
|
| Sepsis | 2 | 2016 | 322 | 0.080 |
Why?
|
| Device Removal | 1 | 2009 | 168 | 0.070 |
Why?
|
| DNA-Binding Proteins | 1 | 2014 | 1242 | 0.070 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2009 | 136 | 0.070 |
Why?
|
| Syndrome | 3 | 2019 | 449 | 0.070 |
Why?
|
| Foreign-Body Migration | 1 | 2007 | 39 | 0.070 |
Why?
|
| Computed Tomography Angiography | 2 | 2019 | 147 | 0.070 |
Why?
|
| Aneurysm | 1 | 2007 | 60 | 0.070 |
Why?
|
| Regression Analysis | 1 | 2008 | 590 | 0.070 |
Why?
|
| Pilot Projects | 3 | 2017 | 870 | 0.070 |
Why?
|
| Intracranial Hemorrhages | 1 | 2008 | 130 | 0.070 |
Why?
|
| Europe | 2 | 2017 | 322 | 0.070 |
Why?
|
| Down Syndrome | 2 | 2006 | 55 | 0.070 |
Why?
|
| Cardiomyopathy, Restrictive | 1 | 2006 | 2 | 0.070 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2006 | 7 | 0.070 |
Why?
|
| Haemophilus Infections | 1 | 2006 | 7 | 0.070 |
Why?
|
| Haemophilus influenzae | 1 | 2006 | 15 | 0.070 |
Why?
|
| Pericarditis | 1 | 2006 | 14 | 0.070 |
Why?
|
| Prosthesis Failure | 1 | 2007 | 116 | 0.070 |
Why?
|
| Compartment Syndromes | 1 | 2006 | 13 | 0.070 |
Why?
|
| Troponin T | 1 | 2006 | 39 | 0.070 |
Why?
|
| Transplantation, Homologous | 3 | 2019 | 995 | 0.070 |
Why?
|
| Abdomen | 1 | 2006 | 123 | 0.060 |
Why?
|
| Medical Records | 1 | 2005 | 120 | 0.060 |
Why?
|
| Catheterization | 2 | 2003 | 237 | 0.060 |
Why?
|
| Pulmonary Atresia | 1 | 2004 | 12 | 0.060 |
Why?
|
| Hepatic Veins | 1 | 2004 | 26 | 0.060 |
Why?
|
| Embolization, Therapeutic | 1 | 2007 | 263 | 0.060 |
Why?
|
| Coronary Circulation | 1 | 2004 | 131 | 0.060 |
Why?
|
| Pneumonia, Pneumocystis | 2 | 2001 | 18 | 0.060 |
Why?
|
| Thoracostomy | 2 | 2001 | 10 | 0.060 |
Why?
|
| Pleurodesis | 2 | 2001 | 8 | 0.060 |
Why?
|
| Heart Conduction System | 1 | 2004 | 112 | 0.060 |
Why?
|
| Arteriovenous Fistula | 1 | 2004 | 53 | 0.060 |
Why?
|
| Suture Techniques | 1 | 2005 | 144 | 0.060 |
Why?
|
| Recurrence | 1 | 2007 | 1143 | 0.060 |
Why?
|
| Flucytosine | 1 | 2003 | 11 | 0.060 |
Why?
|
| Medical Illustration | 1 | 2023 | 16 | 0.060 |
Why?
|
| Sheep | 1 | 2003 | 251 | 0.060 |
Why?
|
| Amphotericin B | 1 | 2003 | 34 | 0.060 |
Why?
|
| Ventricular Function, Left | 1 | 2007 | 607 | 0.060 |
Why?
|
| Hemostasis, Surgical | 1 | 2003 | 25 | 0.050 |
Why?
|
| Equipment Design | 2 | 2019 | 420 | 0.050 |
Why?
|
| Tricuspid Valve | 1 | 2003 | 99 | 0.050 |
Why?
|
| Antifungal Agents | 1 | 2003 | 122 | 0.050 |
Why?
|
| Models, Animal | 1 | 2003 | 276 | 0.050 |
Why?
|
| Perioperative Care | 2 | 2019 | 168 | 0.050 |
Why?
|
| Oxygen | 1 | 2007 | 743 | 0.050 |
Why?
|
| Vena Cava, Inferior | 1 | 2003 | 144 | 0.050 |
Why?
|
| Thoracic Surgery, Video-Assisted | 1 | 2002 | 30 | 0.050 |
Why?
|
| Bronchial Fistula | 1 | 2001 | 9 | 0.050 |
Why?
|
| Body Weight | 1 | 2003 | 452 | 0.050 |
Why?
|
| Respiratory Tract Fistula | 1 | 2001 | 9 | 0.050 |
Why?
|
| Intensive Care Units, Pediatric | 2 | 2016 | 104 | 0.050 |
Why?
|
| Pleural Diseases | 1 | 2001 | 14 | 0.050 |
Why?
|
| Thrombectomy | 1 | 2003 | 188 | 0.050 |
Why?
|
| Coronary Angiography | 2 | 2018 | 242 | 0.050 |
Why?
|
| Preoperative Care | 2 | 2014 | 395 | 0.050 |
Why?
|
| Immunohistochemistry | 2 | 2016 | 1793 | 0.050 |
Why?
|
| Labor Stage, First | 1 | 2020 | 3 | 0.040 |
Why?
|
| Labor Presentation | 1 | 2020 | 4 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2007 | 2762 | 0.040 |
Why?
|
| Intubation, Intratracheal | 1 | 2002 | 147 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2017 | 2884 | 0.040 |
Why?
|
| Venous Thrombosis | 1 | 2003 | 252 | 0.040 |
Why?
|
| Animals | 5 | 2019 | 27451 | 0.040 |
Why?
|
| Cholecystitis | 1 | 1999 | 15 | 0.040 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2003 | 333 | 0.040 |
Why?
|
| Galectins | 1 | 2019 | 11 | 0.040 |
Why?
|
| Perioperative Period | 1 | 2019 | 25 | 0.040 |
Why?
|
| Head | 1 | 2020 | 137 | 0.040 |
Why?
|
| Infusion Pumps | 1 | 2019 | 25 | 0.040 |
Why?
|
| Cardioplegic Solutions | 1 | 2019 | 17 | 0.040 |
Why?
|
| Respiration, Artificial | 1 | 2002 | 351 | 0.040 |
Why?
|
| Risk Management | 1 | 2019 | 43 | 0.040 |
Why?
|
| Intraoperative Complications | 1 | 2020 | 185 | 0.040 |
Why?
|
| Blood Proteins | 1 | 2019 | 149 | 0.040 |
Why?
|
| Elective Surgical Procedures | 1 | 2000 | 128 | 0.040 |
Why?
|
| Surface Properties | 1 | 2019 | 131 | 0.040 |
Why?
|
| Albumins | 1 | 2019 | 129 | 0.040 |
Why?
|
| Proof of Concept Study | 1 | 2018 | 48 | 0.040 |
Why?
|
| Kidney Neoplasms | 1 | 2003 | 523 | 0.040 |
Why?
|
| Cause of Death | 2 | 2009 | 269 | 0.040 |
Why?
|
| Electrocardiography | 1 | 2020 | 497 | 0.040 |
Why?
|
| Constriction, Pathologic | 1 | 2019 | 218 | 0.040 |
Why?
|
| Organ Size | 1 | 2019 | 370 | 0.040 |
Why?
|
| Hydrodynamics | 1 | 2017 | 19 | 0.040 |
Why?
|
| Polymers | 1 | 2019 | 195 | 0.040 |
Why?
|
| Tissue Transplantation | 1 | 2017 | 12 | 0.040 |
Why?
|
| Graft Survival | 1 | 2021 | 902 | 0.040 |
Why?
|
| Pulmonary Circulation | 1 | 2017 | 90 | 0.040 |
Why?
|
| Balloon Occlusion | 1 | 2017 | 29 | 0.040 |
Why?
|
| Prenatal Diagnosis | 1 | 2018 | 110 | 0.040 |
Why?
|
| Workflow | 1 | 2017 | 79 | 0.040 |
Why?
|
| Pulmonary Atelectasis | 1 | 1997 | 19 | 0.040 |
Why?
|
| Models, Cardiovascular | 1 | 2017 | 107 | 0.040 |
Why?
|
| Injections | 1 | 2017 | 116 | 0.040 |
Why?
|
| Electrophysiological Phenomena | 1 | 2017 | 51 | 0.040 |
Why?
|
| Thoracic Surgery | 1 | 2017 | 45 | 0.040 |
Why?
|
| Ehlers-Danlos Syndrome | 2 | 2008 | 8 | 0.040 |
Why?
|
| Pneumonia, Ventilator-Associated | 1 | 2016 | 3 | 0.040 |
Why?
|
| Mutation, Missense | 1 | 2018 | 280 | 0.030 |
Why?
|
| Pulmonary Edema | 1 | 1997 | 50 | 0.030 |
Why?
|
| Mediastinitis | 1 | 2016 | 14 | 0.030 |
Why?
|
| ROC Curve | 1 | 2019 | 777 | 0.030 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2016 | 37 | 0.030 |
Why?
|
| Circulatory Arrest, Deep Hypothermia Induced | 1 | 2016 | 5 | 0.030 |
Why?
|
| Brain | 1 | 2007 | 2292 | 0.030 |
Why?
|
| Tunica Media | 1 | 2016 | 16 | 0.030 |
Why?
|
| Gestational Age | 1 | 2017 | 328 | 0.030 |
Why?
|
| Patient Discharge | 1 | 2019 | 322 | 0.030 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2017 | 164 | 0.030 |
Why?
|
| Aortography | 1 | 2016 | 65 | 0.030 |
Why?
|
| Developing Countries | 1 | 2016 | 78 | 0.030 |
Why?
|
| Germ-Line Mutation | 1 | 2018 | 346 | 0.030 |
Why?
|
| Hospitals, Low-Volume | 1 | 2015 | 19 | 0.030 |
Why?
|
| Graft Rejection | 1 | 2021 | 1072 | 0.030 |
Why?
|
| Biopsy, Needle | 1 | 2016 | 231 | 0.030 |
Why?
|
| Operating Rooms | 1 | 2016 | 125 | 0.030 |
Why?
|
| Hospitals, High-Volume | 1 | 2015 | 37 | 0.030 |
Why?
|
| Blood Pressure | 2 | 2010 | 902 | 0.030 |
Why?
|
| Physician's Role | 1 | 2016 | 176 | 0.030 |
Why?
|
| Surgical Wound Infection | 1 | 2016 | 201 | 0.030 |
Why?
|
| Vasoconstrictor Agents | 1 | 2014 | 56 | 0.030 |
Why?
|
| Clinical Competence | 1 | 2020 | 786 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2017 | 462 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2017 | 758 | 0.030 |
Why?
|
| Gene Expression | 1 | 2018 | 1309 | 0.030 |
Why?
|
| Software | 1 | 2018 | 666 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2014 | 358 | 0.030 |
Why?
|
| Sex Factors | 1 | 2016 | 1072 | 0.030 |
Why?
|
| Tetraspanin 24 | 1 | 2012 | 5 | 0.030 |
Why?
|
| Measles Vaccine | 1 | 2012 | 8 | 0.030 |
Why?
|
| Operative Time | 1 | 2013 | 143 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2015 | 1172 | 0.030 |
Why?
|
| Organ Culture Techniques | 1 | 2012 | 135 | 0.030 |
Why?
|
| Cell Cycle | 1 | 2014 | 508 | 0.020 |
Why?
|
| Surgeons | 1 | 2016 | 249 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 885 | 0.020 |
Why?
|
| Epinephrine | 1 | 2011 | 89 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2014 | 398 | 0.020 |
Why?
|
| Cyclosporine | 1 | 1992 | 237 | 0.020 |
Why?
|
| Cardiotonic Agents | 1 | 2011 | 89 | 0.020 |
Why?
|
| Mortality | 1 | 2012 | 149 | 0.020 |
Why?
|
| Rats | 1 | 2017 | 4040 | 0.020 |
Why?
|
| Phenotype | 2 | 2008 | 2447 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2012 | 448 | 0.020 |
Why?
|
| Dopamine | 1 | 2011 | 276 | 0.020 |
Why?
|
| Blood Flow Velocity | 1 | 2010 | 200 | 0.020 |
Why?
|
| Aged | 3 | 2014 | 19126 | 0.020 |
Why?
|
| Warm Ischemia | 1 | 2009 | 31 | 0.020 |
Why?
|
| Neuromuscular Diseases | 1 | 2009 | 31 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2014 | 3024 | 0.020 |
Why?
|
| Disease Progression | 1 | 2012 | 1462 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2009 | 368 | 0.020 |
Why?
|
| Body Temperature | 1 | 2008 | 125 | 0.020 |
Why?
|
| Siblings | 1 | 2008 | 110 | 0.020 |
Why?
|
| Thromboembolism | 1 | 2008 | 119 | 0.020 |
Why?
|
| Survivors | 1 | 2009 | 234 | 0.020 |
Why?
|
| Aortic Rupture | 1 | 2007 | 57 | 0.020 |
Why?
|
| Serotyping | 1 | 2006 | 28 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2009 | 1076 | 0.020 |
Why?
|
| Myosins | 1 | 2006 | 92 | 0.020 |
Why?
|
| Anthropometry | 1 | 2005 | 76 | 0.020 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2007 | 120 | 0.020 |
Why?
|
| Hemorheology | 1 | 2004 | 8 | 0.010 |
Why?
|
| Venae Cavae | 1 | 2004 | 12 | 0.010 |
Why?
|
| Radiography, Thoracic | 1 | 2006 | 324 | 0.010 |
Why?
|
| Prostheses and Implants | 1 | 2004 | 124 | 0.010 |
Why?
|
| Tourniquets | 1 | 2003 | 8 | 0.010 |
Why?
|
| Aorta, Abdominal | 1 | 2003 | 59 | 0.010 |
Why?
|
| Rare Diseases | 1 | 2003 | 69 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2006 | 606 | 0.010 |
Why?
|
| Heart Neoplasms | 1 | 2003 | 63 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2006 | 678 | 0.010 |
Why?
|
| Central Nervous System | 1 | 2003 | 153 | 0.010 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2005 | 262 | 0.010 |
Why?
|
| Bronchoscopes | 1 | 2002 | 4 | 0.010 |
Why?
|
| Genotype | 1 | 2007 | 1852 | 0.010 |
Why?
|
| Methyl Ethers | 1 | 2002 | 33 | 0.010 |
Why?
|
| Fiber Optic Technology | 1 | 2002 | 36 | 0.010 |
Why?
|
| Smoking | 1 | 2005 | 624 | 0.010 |
Why?
|
| Kidney Failure, Chronic | 1 | 2005 | 414 | 0.010 |
Why?
|
| Anesthetics, Inhalation | 1 | 2002 | 97 | 0.010 |
Why?
|
| Nephrectomy | 1 | 2003 | 291 | 0.010 |
Why?
|
| Goats | 1 | 2000 | 18 | 0.010 |
Why?
|
| Bronchi | 1 | 2002 | 229 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2006 | 1254 | 0.010 |
Why?
|
| Cattle | 1 | 2000 | 378 | 0.010 |
Why?
|
| Mice | 1 | 2014 | 11811 | 0.010 |
Why?
|
| Hypertension | 1 | 2005 | 745 | 0.010 |
Why?
|
| Positive-Pressure Respiration | 1 | 1997 | 40 | 0.010 |
Why?
|
| Sclerotherapy | 1 | 1996 | 16 | 0.010 |
Why?
|
| Thoracotomy | 1 | 1996 | 64 | 0.010 |
Why?
|
| Reperfusion Injury | 1 | 1997 | 141 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2005 | 6761 | 0.010 |
Why?
|